Decibel Therapeutics, Inc. Contracts & Agreements

44 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated Exclusive License Agreement between The Curators of the University of Missouri and Decibel Therapeutics, Inc.
License Agreements
Decibel Therapeutics, Inc.
Biotechnology
MO
2023
Second Amendment to License Agreement No. A19433 between University of Florida Research Foundation, Inc. and Decibel Therapeutics, Inc.
License Agreements
Decibel Therapeutics, Inc.
Biotechnology
2023
Decibel Therapeutics, Inc. 2021 Employee Stock Purchase Plan (Amended and Restated)
Stock Agreements
Decibel Therapeutics, Inc.
Biotechnology
DE
2022
Second Amendment to Exclusive License Agreement between University of Missouri and Decibel Therapeutics, Inc.
License Agreements
Decibel Therapeutics, Inc.
Biotechnology
2022
First Amendment to License Agreement No. A19433 between University of Florida Research Foundation, Inc. and Decibel Therapeutics, Inc.
License Agreements
Decibel Therapeutics, Inc.
Biotechnology
2022
Description of Registered Common Stock of Decibel Therapeutics, Inc.
Equity Distribution Agreements
Decibel Therapeutics, Inc.
Biotechnology
2021
Underwriting Agreement for Common Stock Offering between Decibel Therapeutics, Inc. and Underwriters (Citigroup Global Markets Inc. and SVB Leerink LLC)
Underwriting Agreements
Decibel Therapeutics, Inc.
Biotechnology
NY
2021
First Amendment to License Agreement between University of Missouri and Decibel Therapeutics, Inc.
License Agreements
Decibel Therapeutics, Inc.
Biotechnology
2021
Decibel Therapeutics, Inc. Common Stock Certificate
Stock Agreements
Decibel Therapeutics, Inc.
Biotechnology
2021
Third Amended and Restated Investors’ Rights Agreement by and among Decibel Therapeutics, Inc. and Investors (November 2, 2020)
Investor Rights Agreements
Decibel Therapeutics, Inc.
Biotechnology
DE
2021
Indemnification Agreement between Decibel Therapeutics, Inc. and Indemnitee
Indemnification Agreements
Decibel Therapeutics, Inc.
Biotechnology
DE
2021
Decibel Therapeutics, Inc. Restricted Stock Agreement under 2015 Stock Incentive Plan
Stock Agreements
Decibel Therapeutics, Inc.
Biotechnology
DE
2021
Decibel Therapeutics, Inc. Incentive Stock Option Agreement under 2015 Stock Incentive Plan
Stock Agreements
Decibel Therapeutics, Inc.
Biotechnology
DE
2021
Decibel Therapeutics, Inc. Nonstatutory Stock Option Agreement under 2015 Stock Incentive Plan
Stock Agreements
Decibel Therapeutics, Inc.
Biotechnology
DE
2021
Decibel Therapeutics, Inc. Stock Option Agreement under 2021 Stock Incentive Plan
Stock Agreements
Decibel Therapeutics, Inc.
Biotechnology
2021
Decibel Therapeutics, Inc. Restricted Stock Unit Agreement under 2021 Stock Incentive Plan
Stock Agreements
Decibel Therapeutics, Inc.
Biotechnology
DE
2021
Decibel Therapeutics, Inc. Restricted Stock Agreement under 2021 Stock Incentive Plan
Stock Agreements
Decibel Therapeutics, Inc.
Biotechnology
DE
2021
License and Collaboration Agreement between Regeneron Pharmaceuticals, Inc. and Decibel Therapeutics, Inc. (November 15, 2017)
License Agreements
Decibel Therapeutics, Inc.
Biotechnology
NY
2021
Exclusive Patent License Agreement between University of Florida Research Foundation and Decibel Therapeutics, Inc.
License Agreements
Decibel Therapeutics, Inc.
Biotechnology
FL
2021
License Agreement between The Regents of the University of California and Decibel Therapeutics for Otoferlin Compositions and Methods
License Agreements
Decibel Therapeutics, Inc.
Biotechnology
FL
2021
Exclusive License Agreement between The Curators of the University of Missouri and Decibel Therapeutics, Inc.
License Agreements
Decibel Therapeutics, Inc.
Biotechnology
MO
2021
Contingent Value Rights Agreement among Regeneron Pharmaceuticals, Symphony Acquisition Sub, and Computershare (September 25, 2023)
Decibel Therapeutics, Inc.
Biotechnology
DE
2023
Agreement and Plan of Merger among Decibel Therapeutics, Inc., Regeneron Pharmaceuticals, Inc., and Symphony Acquisition Sub, Inc. dated August 8, 2023
Merger Agreements
Decibel Therapeutics, Inc.
Biotechnology
2023
Contingent Value Rights Agreement among Regeneron Pharmaceuticals, Symphony Acquisition Sub, and Rights Agent
Decibel Therapeutics, Inc.
Biotechnology
DE
2023
Separation and Severance Agreement between Decibel Therapeutics, Inc. and Elisabeth Leiderman
Separation Agreements
Decibel Therapeutics, Inc.
Biotechnology
MA
2022
Severance and Change in Control Benefits Agreement between Decibel Therapeutics, Inc. and Executive
Severance Agreements
Decibel Therapeutics, Inc.
Biotechnology
MA
2021
2015 Stock Incentive Plan of Decibel Therapeutics, Inc.
Bonus & Incentive Agreements
Decibel Therapeutics, Inc.
Biotechnology
DE
2021
Decibel Therapeutics, Inc. 2021 Stock Incentive Plan
Bonus & Incentive Agreements
Decibel Therapeutics, Inc.
Biotechnology
DE
2021
Decibel Therapeutics, Inc. 2021 Employee Stock Purchase Plan
Bonus & Incentive Agreements
Decibel Therapeutics, Inc.
Biotechnology
DE
2021
2015 Stock Incentive Plan of Decibel Therapeutics, Inc.
Bonus & Incentive Agreements
Decibel Therapeutics, Inc.
Biotechnology
DE
2021
Decibel Therapeutics, Inc. 2021 Stock Incentive Plan
Bonus & Incentive Agreements
Decibel Therapeutics, Inc.
Biotechnology
DE
2021
Decibel Therapeutics, Inc. 2021 Employee Stock Purchase Plan
Bonus & Incentive Agreements
Decibel Therapeutics, Inc.
Biotechnology
DE
2021
Lease Agreement between Boylston West LLC and Decibel Therapeutics, Inc. for Van Ness, Boston, MA
Lease Agreements
Decibel Therapeutics, Inc.
Biotechnology
DE
2021
Consulting Agreement between Decibel Therapeutics, Inc. and Laurence Reid, PhD (November 2019)
Consulting Agreements
Decibel Therapeutics, Inc.
Biotechnology
2021
Decibel Therapeutics, Inc. Employment Agreement with Laurence Reid as Chief Executive Officer
Employment Agreements
Decibel Therapeutics, Inc.
Biotechnology
2021
Decibel Therapeutics, Inc. Change in Control Agreement with Laurence Reid
Change of Control Agreements
Decibel Therapeutics, Inc.
Biotechnology
MA
2021
Decibel Therapeutics, Inc. Employment Offer Letter to Steve as Chief Executive Officer (June 17, 2016)
Employment Agreements
Decibel Therapeutics, Inc.
Biotechnology
2021
Decibel Therapeutics, Inc. Employment Offer Letter to John Lee (Senior Vice President, Pharmaceutical Development)
Employment Agreements
Decibel Therapeutics, Inc.
Biotechnology
2021
Decibel Therapeutics, Inc. Employment Agreement with Lis as Chief Financial Officer
Employment Agreements
Decibel Therapeutics, Inc.
Biotechnology
2021
Decibel Therapeutics, Inc. Employment Offer Letter to Anna M. Trask
Employment Agreements
Decibel Therapeutics, Inc.
Biotechnology
2021
Decibel Therapeutics, Inc. Employment Offer Letter to Ronald T. Vigliotta (Senior Director, Finance)
Employment Agreements
Decibel Therapeutics, Inc.
Biotechnology
2021
Decibel Therapeutics, Inc. Change in Control Agreement with Employee – Equity Acceleration Terms
Change of Control Agreements
Decibel Therapeutics, Inc.
Biotechnology
MA
2021
Sublease Agreement between United HealthCare Services, Inc. and Decibel Therapeutics, Inc. dated June 20, 2019
Lease Agreements
Decibel Therapeutics, Inc.
Biotechnology
MA
2021
Consulting Agreement between Decibel Therapeutics, Inc. and Steven H. Holtzman
Consulting Agreements
Decibel Therapeutics, Inc.
Biotechnology
2021